PROPOXYPHENE - ANVISA Registration 80146502323
Access comprehensive regulatory information for PROPOXYPHENE in Brazil's medical device market through Pure Global AI's free database. This Risk Class II medical device is registered under ANVISA number 80146502323 and manufactured by MICROGENICS CORPORATION. The registration is held by ABBOTT LABORATORIOS DO BRASIL LTDA with validity until currently active (VIGENTE).
This page provides complete technical specifications for this device, regulatory compliance details, 4 companies making the same product including ROCHE DIAGNOSTICS GMBH (MANNHEIM), SIEMENS HEALTHACARE DIAGNOSTICS INC, and 4 recent registrations in the same technical category. Pure Global AI offers free access to over 100,000+ Brazilian medical device registrations, helping global MedTech companies navigate ANVISA regulations, identify competitors, and discover partnership opportunities efficiently.
Device Details
Registration Details
80146502323
25351626516202081
56998701000116
Company Information
Dates and Status
Dec 17, 2020
VIGENTE
09/18/2025 19:00:01
PROPOXIFENO
PPX (ONLINE DAT Propoxyphene Plus)_cobas c
ROCHE DIAGNOSTICS GMBH (MANNHEIM)
10287411517
Jul 20, 2020
PROPOXIFENO
FAST TEST PPX
GUANGZHOU WONDFO BIOTECH CO., LTD.
80258020089
Jan 14, 2019
PROPOXIFENO
Atellica CH Propoxifeno (Ppx)
SIEMENS HEALTHACARE DIAGNOSTICS INC
10345162145
Dec 18, 2017
PROPOXIFENO
PROPOXYPHENE PLUS
ROCHE DIAGNOSTICS GMBH
10287410677
Feb 06, 2008

